EMBERA NEUROTHERAPEUTICS INC has a total of 37 patent applications. It decreased the IP activity by 18.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals are FK SLAVYANSKAYA APTEKA LTD, ONCORENA AB and MENDOZA WENDELL G.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | China | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | Australia | 2 | |
#7 | Brazil | 2 | |
#8 | Japan | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Detke Michael | 20 |
#2 | Straub Julie | 15 |
#3 | Gloff Carol | 15 |
#4 | Fox Barbara S | 9 |
#5 | Phillips Martin | 8 |
#6 | Linke Robert | 8 |
#7 | Guerin Glenn | 7 |
#8 | Goeders Nicholas E | 7 |
#9 | Borah Kripanath | 5 |
#10 | Duvvuri Muralikrishna | 5 |
Publication | Filing date | Title |
---|---|---|
WO2018213713A1 | Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease | |
WO2018165649A1 | Pharmaceutical compositions and uses thereof | |
CA3016335A1 | Compositions and methods for treating addiction or substance use disorders | |
CA3014876A1 | Compositions and methods for treating substance abuse disorders | |
CA2990413A1 | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
CN103037864A | Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |